(Q44887498)

7 December 2017

Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

22 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

22 October 2022

author name string

E. G. Elias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656805

22 October 2022

D. A. Vachon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656805

22 October 2022

M. S. Didolkar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656805

22 October 2022

J. Aisner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656805

22 October 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

full work available at URL

7 December 2017

https://api.elsevier.com/content/article/PII:000296109190076P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

https://api.elsevier.com/content/article/PII:000296109190076P?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

The American Journal of Surgery

22 October 2022

published in

1 reference

7 December 2017

162

1 reference

7 December 2017

3

1 reference

7 December 2017

231-235

1 reference

Inflammatory breast cancer

7 December 2017

2

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Management of inflammatory carcinoma of breast with combined modality approach - an update

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Epidemiologic features of rapidly progressing breast cancer in Tunisia

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis

22 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Mastectomy as an Adjunct to Combination Chemotherapy

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Management of inflammatory carcinoma of the breast with combined modality therapy including intraarterial infusion chemotherapy as an induction therapy. Long-term follow-up results of 28 patients

22 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

Surgery as part of a combined modality approach for inflammatory breast carcinoma

22 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9610(91)90076-P

22 October 2022

Identifiers

1 reference

7 December 2017

1 reference